Holistic care in mild upper respiratory tract infections (MURTIs): an approach to individualized care management

Abstract

Although mild upper respiratory tract infections (MURTIs) are typically self-limiting and benign, they can substantially impair a patient’s quality of life. The wide range of pathogens causing MURTIs often necessitates a symptomatic treatment approach rather than a pathogen-specific treatment. The present article introduces a patient-centred classification system that distinguishes between self-care-oriented, pharmacist- oriented and physician-oriented patients. Building on this framework, we propose a 360° holistic care model that considers contextual factors and addresses the whole person, under the premise that the effectiveness, safety and suitability of the treatment are tailored to the individual’s symptoms and circumstances. To support practical implementation, a stepwise guide for MURTI management is presented, encompassing all steps from initial patient assessment to pharmacological and non-pharmacological treatment approaches, lifestyle advice, patient education, and follow-up care. This structured approach not only facilitates symptom resolution but also promotes long-term health by empowering patients with the knowledge, tools and support they need to maintain their well-being. By shifting the focus from isolated symptom management to comprehensive care, our 360° holistic care model may enhance the overall treatment experience and outcome for patients affected by MURTIs.

Download the Plain Language Summary of this article: https://www.drugsincontext.com/wp-content/uploads/2025/12/dic.2025-7-12-PLS.pdf